MK-3655

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-3655, covering 2024-04-29 to 2024-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001) [Phase 2]